Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

No doubt this could be a huge opportunity as epilepsy by itself is throughout the world. "BeaMed has successfully completed the manufacturing of its first-ever MRI compatible fiber optic probes, marking a major technical milestone in its development of an advanced laser technology with respect to shaping energy and matching it to patient specific anatomy, a novel concept that BeaMed is proving a reality resulting in a major milestone in the advancement of the StingRay System. The completion of these probes allows for comprehensive integration tests, involving the unique MRI compatible fiber optics, an MRI interface software suite, special algorithms to simplify damage estimation, and custom insertion tools, planned to commence in late June 2023".

An initial area of emphasis of the StingRay System will be for the treatment of epilepsy. Epilepsy affects millions of people worldwide, causing recurrent seizures that significantly diminish their quality of life. Traditional treatment methods, such as medication and surgery, possess limitations and may not be effective for all patients. Recognizing the critical need for innovation, BeaMed has developed an advanced laser system designed to revolutionize epilepsy treatment".

How Common Is Epilepsy?
By Mary Nolan-Pleckham, RN
Published on December 12, 2022
Medically reviewed by Smita Patel, MD

Each year, about 5 million people worldwide are diagnosed with epilepsy, a brain condition that causes repeated seizures.
World Health Organization (WHO).
It is estimated that about 1 in 100 people in the United States have active epilepsy. More than 75% of those are adults.